Customize Consent Preferences

We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.

The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ... 

Always Active

Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.

No cookies to display.

Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.

No cookies to display.

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.

No cookies to display.

Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.

No cookies to display.

Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously and to analyze the effectiveness of the ad campaigns.

No cookies to display.

ADVERTISEMENT

A New Drug that Prevent Malaria Parasites from Infecting Mosquitos

Compounds have been identified which could prevent malaria parasites from infecting mosquitos, thereby stopping the spread of malaria.

Malaria is a global burden and it claims 450,000 lives each year globally. The main symptoms of malaria include high fevers, chills and flu-like symptoms. An important aspect in eliminating a communicable infectious disease like malaria is to prevent its transmission.

The spread of malaria

Malaria is not transmitted through person to person contact but mosquitos which are carrying the malaria parasite are the disease’s main transmitter. The complex life cycle of malaria parasite acts as a major hindrance for treating and stopping transmission of the disease. When a person gets infected with malaria, asexual forms of the parasite exist in one’s bloodstream which cause symptoms. However, in addition to asexual forms, sexual forms of both male and female also exist which lie dormant i.e. not reactive at all. Such forms of the parasite are difficult to combat using conventional antimalarial drugs in comparison to asexual forms which are well targeted by drugs. After undergoing sexual intercourse these male and female parasite forms create new ‘infectious’ asexual parasites which collect at the mosquito’s salivary gland, to be passed onto the next human victim of malaria through fly bite. Since antimalarial drugs have no effect on dormant sexual forms of the parasite they rapidly mature and multiply inside the mosquito and can readily cause a fresh infection. In a way, survivors who have been cured of malaria are still carriers and contributors in spread of malaria. In this vicious cycle more people can get infected when bitten by these mosquitos. Finding a solution to stop the spread of malaria is very challenging.

New possible drug for malaria

A study published in Nature Communications is based upon the idea that when parasite is inside the mosquito, its sexual forms are very active, in fact they are cell types which are known to replicate very fast and thus are excellent potential drug targets. Though it’s very difficult to target them with standard traditional drugs. A team of researchers led by Imperial College London set the goal of finding compounds which could disrupt sexual forms of the parasite, this can then inhibit creation of infectious asexual forms. They first set out to find conditions to mimic the embroilment inside the mosquito which would stimulate the sexual forms of the parasite. Once apt conditions were found, they miniaturized this process to examine it under a microscope. This whole process of finding the right conditions and miniaturizing the environment took several years. Researchers identified several chemical compounds which can robustly prevent malaria parasite to develop and mature inside a mosquito thus preventing the mosquito from being infected. They screened around 70,000 compounds to see the effect on active sexual forms of the parasites and then successfully pinpointed six potent compounds which were active and safe and could inhibit this activity in human cells. One compound out of these has already been tested in a mouse model where it blocks transmission of parasite from mice. Further research can determine how each of these six compounds work which can also shed more light into the parasite transmission process and how such compounds could be modulated as future drugs.

These compounds are called antimalarial drugs which can ‘protect mosquitos’ instead and thereby prevent further infectious journey of the parasites. Currently available antimalarial drugs are not very efficient because parasites become resistant to drugs over time. A patient has to struggle with the treatment. The main transmission of malaria happens in mosquito and this process is a crucial target for designing beneficial and resistance-proof drugs. This could help to eliminate malaria. There are several challenges to the approach as giving these drugs directly to mosquitos is nearly impossible. The drug has to be strong and stable enough that when it is administered to a human, it must persist till it gets transferred from human to the mosquito.

If mosquitos – the important carriers of malaria parasite – don’t get malaria then they cannot transmit the disease to humans. A drug which can combine the capability of existing antimalarials and the aspects from this new study would be a much powerful choice for eliminating the disease and would be useful for entire communities struggling with malaria.

***

{You may read the original research paper by clicking the DOI link given below in the list of cited source(s)}

Source(s)

Delves MJ et al. 2018. A high throughput screen for next-generation leads targeting malaria parasite transmission. Nature Communications. 9(1). https://doi.org/10.1038/s41467-018-05777-2

***

SCIEU Team
SCIEU Teamhttps://www.scientificeuropean.co.uk
Scientific European® | SCIEU.com | Significant advances in science. Impact on humankind. Inspiring minds.

Subscribe to our newsletter

To be updated with all the latest news, offers and special announcements.

Most Popular Articles

Molecular Origin of Life: What Formed First – Protein, DNA or RNA or a...

‘Several questions about origin of life have been answered,...

Anxiety Relief Through Probiotic and Non-Probiotic Diet Adjustments

A systematic review provides comprehensive evidence that regulating microbiota...

The Lambda Variant (C.37) of SARS-CoV2 Has Higher Infectivity and Immune Escape

The Lambda variant (lineage C.37) of SARS-CoV-2 was identified...
- Advertisement -
93,340FansLike
47,367FollowersFollow
1,772FollowersFollow
30SubscribersSubscribe